Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 4:00 pm Purchase | 13G | BIOATLA INC BCAB | TANG CAPITAL MANAGEMENT LLC | 874,076 1.800% | 874,076 (New Position) | View |
2024-10-02 4:30 pm Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 1,237,909 2.560% | -1,410,563 (-53.26%) | View |
2024-09-06 4:59 pm Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 2,648,472 5.500% | -1,252,842 (-32.11%) | View |
2024-08-07 4:26 pm Purchase | 13G | BIOATLA INC BCAB | MILLENNIUM MANAGEMENT LLC | 2,414,815 5.000% | 2,414,815 (New Position) | View |
2024-07-08 4:32 pm Sale | 13G | BIOATLA INC BCAB | BlackRock Inc. BLK | 791,560 1.600% | -2,092,454 (-72.55%) | View |
2024-04-16 09:15 am Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 3,901,314 8.100% | -319,083 (-7.56%) | View |
2024-02-14 4:00 pm Sale | 13G | BIOATLA INC BCAB | TANG CAPITAL PARTNERS LP | 2,524,076 5.300% | -600,000 (-19.21%) | View |
2024-02-09 4:58 pm Purchase | 13G | BIOATLA INC BCAB | SHORT JAY M PHD | 3,458,190 7.200% | 476,154 (+15.97%) | View |
2024-02-06 3:57 pm Purchase | 13G | BIOATLA INC BCAB | ACORN BIOVENTURES L.P. | 4,032,046 8.400% | 1,305,591 (+47.89%) | View |
2024-01-29 5:25 pm Purchase | 13G | BIOATLA INC BCAB | BlackRock Inc. BLK | 2,884,014 6.000% | 2,884,014 (New Position) | View |
2023-04-27 12:11 pm Purchase | 13G | BIOATLA INC BCAB | ACORN BIOVENTURES L.P. | 2,726,455 5.700% | 2,726,455 (New Position) | View |
2023-02-27 4:14 pm Purchase | 13G | BIOATLA INC BCAB | SHORT JAY M PHD | 2,982,036 6.400% | 280,709 (+10.39%) | View |
2023-02-14 4:00 pm Purchase | 13G | BIOATLA INC BCAB | TANG CAPITAL PARTNERS LP | 3,124,076 8.600% | 835,176 (+36.49%) | View |
2023-02-14 3:10 pm Purchase | 13G | BIOATLA INC BCAB | Cormorant Asset Management LP | 3,680,365 7.980% | 1,642,150 (+80.57%) | View |
2023-02-09 11:12 am Sale | 13G | BIOATLA INC BCAB | VANGUARD GROUP INC | 1,931,039 4.190% | -333,615 (-14.73%) | View |
2023-02-06 2:49 pm Sale | 13G | BIOATLA INC BCAB | WELLINGTON MANAGEMENT GROUP LLP | 1,102 0.000% | -3,231,378 (-99.97%) | View |
2023-01-09 5:00 pm Purchase | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 4,220,397 9.200% | 1,972,873 (+87.78%) | View |
2022-06-10 11:04 am Sale | 13G | BIOATLA INC BCAB | FMR LLC | 315,211 0.877% | -3,605,461 (-91.96%) | View |
2022-04-28 4:00 pm Purchase | 13G | BIOATLA INC BCAB | TANG CAPITAL PARTNERS LP | 2,288,900 6.400% | 2,288,900 (New Position) | View |
2022-02-14 4:11 pm Purchase | 13G | BIOATLA INC BCAB | SHORT JAY M PHD | 2,701,327 7.540% | 2,701,327 (New Position) | View |